After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.

Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.

Columnist Patrick Moeschen turns to classic writers and poets to express how he is choosing hope in life with limb-girdle muscular dystrophy.

Dosing has begun in a Phase 2 clinical trial testing the experimental oral therapy SAT-3247 in boys with Duchenne muscular ...

Columnist Shalom Lim has discovered that a personal sense of belonging is built through simple presence. Art can help foster ...

Lasting gains in swallowing ability have been reported for four people with oculopharyngeal muscular dystrophy given gene therapy in a trial.

Guest writer Matthew Busch says that, despite the setbacks and surgeries he's endured, he's now thriving in life with Duchenne MD.

A clinical trial testing Duchenne gene-editing therapy candidate PBGENE-DMD will soon launch in the U.S., having won ...

An honest answer about her sons would mean talking about all the things Duchenne MD has taken from them, writes columnist.

A Phase 3 clinical trial testing SGT-003, a gene therapy candidate for Duchenne muscular dystrophy (DMD), will start dosing patients soon.

Rob Stemple is a lifelong advocate for people with disabilities. He was diagnosed with FSHD in 1971 at age 14. Rob struggled with its’ affects for over 50 years. He lost his eyesight in a devastating ...